Portfolio Category: Exits
![Seahorse Bioscience Seahorse Bioscience](https://www.newscienceventures.com/wp-content/uploads/2020/11/seahorsewhite.png)
Seahorse Bioscience
Acquired by Agilent Technologies. Developer of tools for measuring cell metabolism.
Read More![K2M K2M](https://www.newscienceventures.com/wp-content/uploads/2020/11/k2mwhite.png)
![FlowCardia FlowCardia](https://www.newscienceventures.com/wp-content/uploads/2020/11/flowcardiawhite.png)
FlowCardia
Acquired by C.R. Bard. Developer of endovascular devices for the treatment of coronary and peripheral CTO.
Read More![Dezima Dezima](https://www.newscienceventures.com/wp-content/uploads/2020/11/dezimawhite.png)
![Conor Medsystems Conor Medsystems](https://www.newscienceventures.com/wp-content/uploads/2020/11/conorwhite.png)
Conor Medsystems
Acquired by Johnson & Johnson. Focused on the development of drug-eluting stents to treat coronary artery disease.
Read More![Ception Ception](https://www.newscienceventures.com/wp-content/uploads/2020/11/ceptionwhite.png)
![Biovex Biovex](https://www.newscienceventures.com/wp-content/uploads/2020/11/biovexwhite.png)
![Akarna Therapeutics Akarna Therapeutics](https://www.newscienceventures.com/wp-content/uploads/2020/11/akarna_blue_org_mag_resized37.jpeg)
Akarna Therapeutics
Acquired by Allergan. Focused on the development of a small molecule therapy for the treatment of NASH.
Read More![Therox Therox](https://www.newscienceventures.com/wp-content/uploads/2020/11/theroxwhite84.png)
![Sensor Platforms Sensor Platforms](https://www.newscienceventures.com/wp-content/uploads/2020/11/sensorplatformswhite-1.png)
Sensor Platforms
Acquired by Audience. Developer of algorithms and software enabling consumer applications to better understand user contexts and intent.
Read More![Lightwire Lightwire](https://www.newscienceventures.com/wp-content/uploads/2020/11/lightwirewhite.png)